-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GLS-012 in Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GLS-012 in Melanoma Drug Details: GLS-012 is under development for the treatment of advanced melanoma,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GLS-012 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GLS-012 in Solid Tumor Drug Details: GLS-012 is under development for the treatment of advanced...
-
Product Insights
GLS Schleiden Wind Farm_Repowered
GLS Schleiden Wind Farm_Repowered is an Onshore Wind project located in North Rhine-Westphalia, Germany. The project came online in 2015. Empower your strategies with our GLS Schleiden Wind Farm_Repowered report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability...
-
Product Insights
DNV GL Kom Ombo Solar PV Park
DNV GL Kom Ombo Solar PV Park is a solar PV project located in Aswan, Egypt. The project is owned and developed by TSK Electronica y Electricidad SA. The project came online in 2020. Empower your strategies with our DNV GL Kom Ombo Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GL-7190 in Inflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GL-7190 in Inflammation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GL-7190 in Inflammation Drug Details:GL-7190 is under development for the treatment of immunological disorders...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GL-0034 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GL-0034 in Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GL-0034 in Obesity Drug Details: GL-0034 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GLS-6100 in Hepatitis C
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GLS-6100 in Hepatitis C report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GLS-6100 in Hepatitis C Drug Details: GLS-6100 is under development for the prevention...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GL-0034 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GL-0034 in Type 2 Diabetes report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zimberelimab in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zimberelimab in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zimberelimab in Gastric Cancer Drug Details: Zimberelimab (Sepalizumab) is a human monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zimberelimab in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zimberelimab in Hepatocellular Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zimberelimab in Hepatocellular Carcinoma Drug Details: Zimberelimab (Sepalizumab) is a human monoclonal...